CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release regarding grant of final approval from USFDA for ANDA, to our subsidiary Caplin Steriles Limited is enclosed herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window
The details of Closure of Trading Window for the quarter ending December 31, 2023 is enclosed herewith. CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Details of allotment of shares pursuant to ESOP is attached herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Cessation
The details of resignation of Senior Management Personnel''s is enclosed herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached herewith CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript is enclosed CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate is attached